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Abstract
In human immunodeficiency virus (HIV) the viral envelope proteins gp41 and gp120 form a non-covalent complex, which
is a potential target for AIDS therapies. In addition gp41 plays a possible role in HIV infection of B cells via the complement
system. In an effort to better understand the molecular interactions of gp41, the structure of the HIV gp41 ectodomain has
been modeled using the NMR restraints of the simian immunodeficiency virus (SIV) gp41 ectodomain (M. Caffrey, M. Cai,
J. Kaufman, S.J. Stahl, P.T. Wingfield, A.M. Gronenborn, G.M. Clore, Solution structure of the 44 kDa ectodomain of SIV
gp41, EMBO J. 17 (1998) 4572^4584). The resulting model presents the first structural information for the HIV gp41 loop,
which has been implicated to play a direct role in binding to gp120 and C1q of the complement system. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The human immunode¢ciency virus (HIV) enve-
lope proteins gp41 and gp120 form a non-covalent
complex on the viral surface and play critical roles in
HIV infection (reviewed in [1,2]). Gp120 directs HIV
to the appropriate target cell by binding to the host
receptor proteins CD4 and a chemokine receptor.
Gp41 mediates fusion of the HIV membrane with
the target cell membrane, thereby allowing introduc-
tion of the viral genome into the target cell. The
essential roles played by gp41 and gp120 make
them targets for AIDS therapies. Such therapies
would be especially attractive because they are alter-
native and complementary to current therapies such
as highly active anti-retroviral treatments (HAART)
[3]. In light of recent evidence that HAART therapies
are ine¡ective in 20^50% of treated patients [4], new
therapies based on alternative targets are clearly of
paramount importance. Structural information on
the gp41-gp120 complex is important for the devel-
opment of new therapies. Firstly, a full understand-
ing of the antigenic properties of the gp41-gp120
complex is of interest for the development of future
vaccines against HIV. Secondly, the gp41-gp120
complex is a potential target for novel drug therapies
designed to disrupt the complex and hence the func-
tion. Unfortunately, there is no structural informa-
tion available for the gp41-gp120 complex. Con-
sequently, current knowledge is limited to the
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structures of various domains of gp41 and gp120 in
isolation. In the case of gp120, there is a recent crys-
tal structure for large regions of the HIV gp120 in
complex with regions of the CD4 receptor and a
monoclonal antibody that inhibits gp120 binding to
the chemokine receptor [5^7]. However, mutagenesis
and deletion studies have suggested that the C1 and
C5 domains of gp120, which are largely missing in
the gp120 crystal structure but would be expected to
be proximal to one another, are involved in the in-
teraction with gp41 [8,9]. In the case of gp41, there
have been numerous crystal structures of the simian
immunode¢ciency virus (SIV) and HIV gp41 ectodo-
mains, the extracellular region of gp41 that binds to
gp120, in isolation [10^14]. Moreover, the solution
structure and dynamic properties of the SIV gp41
ectodomain have been determined by NMR spectros-
copy [15^18]. Importantly, the NMR studies were
able to characterize the structure and dynamic prop-
erties of an approx. 30 residue conserved loop region,
which is missing from the available crystal structures,
but well de¢ned in the solution state [16]. Mutagen-
esis and structural studies have suggested that the
gp41 loop region binds to gp120 [16,19]. More re-
cently, evidence for a direct interaction between the
gp41 loop region and the gp120 C1 and C5 regions
has come from a mutagenesis study that demon-
strated disul¢de formation between non-native cys-
teines placed in the gp41 loop and the gp120 C1 and
C5 regions [20]. In addition, the gp41 loop region
has been shown to interact with C1q of the comple-
ment system [21,22]. Interestingly, the gp41-C1q
interaction may play an important role in the in-
fection of B cells, which may serve as an alternative
reservoir for HIV [23]. Taken together, the inter-
molecular interactions of the gp41 loop region
make it highly desirable to obtain high resolution
structural information for this region of gp41. In
the present paper, a model for the structure of the
HIV gp41 ectodomain is presented, which is based
on the solution structure of the SIV gp41 ectodomain
[15,16].
2. Experimental
The HIV gp41 ectodomain structure was calcu-
lated by the program CNS [24]. The protocol con-
sisted of four steps: (1) high temperature torsion
angle molecular dynamics (TAD) starting from an
extended conformation; (2) slow cooling TAD; (3)
slow cooling Cartesian dynamics; (4) conjugate gra-
dient minimization. For the ¢rst step, the tempera-
ture was set to 50 000 K for 2000 steps of 15 fs. In
this step, the force constants for NOE, dihedral an-
gles, and van der Waals forces were 150 kcal/mol/Aî 2,
100 kcal/mol/rad2 and 0.1 kcal/mol/Aî 4, respectively.
For the second step, the temperature was set to
50 000 K and cooled to 0 K over 1000 steps of
15 fs. In this step, the force constants for NOE,
dihedral angles, and van der Waals forces were 150
kcal/mol/Aî 2, 200 kcal/mol/rad2 and 0.1^1.0 kcal/mol/
Aî 4, respectively. For the third step, the starting tem-
perature was set to 2000 K and cooled to 0 K in 3000
steps of 5 fs. In this step, the force constants for
NOE, dihedral angles, and van der Waals forces
were 150 kcal/mol/Aî 2, 200 kcal/mol/rad2 and 1.0^
4.0 kcal/mol/Aî 4, respectively. In the ¢nal step, 200
steps of conjugate gradient minimization were per-
formed. In this step, the force constants for NOE,
dihedral angles, and van der Waals forces were 75
kcal/mol/Aî 2, 400 kcal/mol/rad2 and 1.0 kcal/mol/Aî 4,
respectively. In steps 2^4, an energy term for non-
crystallographic symmetry (NCS) was included with
a force constant of 300 kcal/mol/Aî 2. In all steps, an
energy term for a conformational database was in-
cluded with a force constant of 1.0. The P and i
dihedral angles within the helical regions were set
to the SIV values of 365‡ þ 15‡ and 345‡ þ 15‡, re-
spectively. In the loop region, the P angle of con-
served residues was set to the SIV gp41 values. The
hydrogen bonds of the helical regions were included
in the calculation as distance restraints. The long
range NOEs were taken from the SIV data set be-
tween homologous hydrogens. NOEs between ho-
mologous hydrogens were de¢ned as: (1) those be-
tween hydrogens of conserved residues (e.g., leucine-
valine); (2) those between HN, HK or HL and a hy-
drogen of a conserved residue; (3) those between HN,
HK or HL of two di¡erent residues. The ¢nal data set
included 105 P angles, 93 i angles, 93 hydrogen
bonds, and 269 long range NOEs per monomer (ap-
prox. two per residue). Figures were generated by the
molecular graphics program MOLMOL [25].
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3. Results and discussion
As noted above, X-ray crystallography studies
have been highly successful in giving information
about the helical regions of the gp41 ectodomain;
however, in all cases to date the loop region was
either removed to facilitate crystallization [10^13]
or not visible in the crystal structure [14]. Thus it
seems unlikely that the HIV gp41 loop region will
be determined by crystallography studies. In con-
trast, the structure of the SIV gp41 ectodomain con-
taining the loop region was successfully determined
by NMR spectroscopy [15,16], which demonstrates
the feasibility of determining the HIV gp41 ectodo-
main structure by NMR spectroscopy. However, the
SIV gp41 structure was very challenging for NMR
studies due to the large molecular mass of the com-
plex (44 kDa) and the signi¢cant amount of spectral
overlap present in a largely helical protein [15]. As a
consequence, the NMR study on the SIV gp41 ecto-
domain required approx. 2 years of full time e¡ort
and thus a NMR-based structure determination of
the HIV gp41 ectodomain is relegated to some time
in the future. As an alternative, the HIV gp41 ecto-
domain structure has been modeled using the NMR
data available for the SIV gp41 ectodomain [15,16].
The rationale for using the SIV NMR data is that
HIV and SIV gp41 share functional, biochemical,
and structural similarities, as well as a high degree
of sequence identity [26]. The sequence identity can
be broken down as follows: 60% in the N-terminal
helix, 46% in the loop region, and 49% in the C-
terminal helix (Fig. 1). For the present calculation,
the structural information consisted of short range
and long range information derived from NMR
studies of the SIV gp41 ectodomain. As summarized
in Fig. 1, three types of data were employed: P and i
dihedral angles, hydrogen bonds, long range NOEs
between homologous hydrogens (cf. Section 2 for de-
tails). An ensemble of ten low energy structures with
no NOE violations s 0.5 Aî and no dihedral angle
violations s 5‡ is shown in Fig. 2a. For this ensem-
ble, the RMSD of the backbone and heavy atoms to
the mean structure is 1.3 and 2.0 Aî , respectively. Due
to a smaller number of restraints, the RMSD of the
HIV structure is larger than that of the SIV structure
(the RMSD of the SIV gp41 ectodomain backbone
and heavy atoms was 0.6 and 0.9 Aî , respectively).
Nonetheless, the ensemble RMSD of the HIV gp41
ectodomain structures suggests that it is a relatively
well-determined solution structure. As shown in Fig.
2a, the RMSD of the HIV gp41 loop region is larger
than that of the helical regions (the RMSD of the
helix backbone and heavy atoms is 0.6 Aî and 1.2 Aî ,
Fig. 1. Alignment of the SIVsm and HIV-1 gp41 ectodomains. Numbering corresponds to that the of the HIV-1 gp41 ectodomain.
Conserved residues are highlighted. The secondary structures are derived from the solution structure of the SIV gp41 ectodomain [16].
The NMR-based data used in the structure calculation of the HIV gp41 ectodomain are summarized as: +, P and i angles;
3, P angle; = , hydrogen bonds; X, long range NOEs between homologous hydrogens (cf. Section 2).
BBADIS 62030 30-5-01 Cyaan Magenta Geel Zwart
M. Ca¡rey / Biochimica et Biophysica Acta 1536 (2001) 116^122118
respectively). In the case of the SIV gp41 ectodo-
main, a larger RMSD was also observed for the
loop [16]. Based on nuclear relaxation rates and hy-
drogen exchange properties of the SIV gp41 ectodo-
main, the loop region is clearly more mobile than the
helical regions [15^17]. The increased mobility of the
loop region has been suggested to be due to the
absence of gp120 interaction domains, which could
stabilize the loop structure [16].
As expected, the global fold of the HIV gp41 ec-
todomain is very similar to that of the SIV gp41
ectodomain. However, there are two di¡erences be-
tween the SIV and HIV gp41 ectodomain structures,
as highlighted in Fig. 2b. Firstly, the present calcu-
lation introduced a disul¢de linked cysteine pair,
which is highly conserved among the envelope pro-
teins of retroviridae [26]. In contrast, the SIV gp41
ectodomain structure utilized a double mutant in
which the two cysteines were substituted by alanine
residues to alleviate possible non-speci¢c intermolec-
ular cross-linking. The substitution of the cysteines
clearly has a minimal e¡ect on the loop structure as
evidenced by the 15N-edited HSQC spectra of the
wild-type and double mutant, which exhibit virtually
indistinguishable spectra [15]. It is important to note,
however, that the loop region of the mutant lacking
disul¢de bonds may well be less stable and more
dynamic than that of the wild-type. In any case,
the HIV loop structure presented here presumably
represents a structure that is closer to that of the
native form. Secondly, the HIV gp41 ectodomain
contains a four residue insertion in the loop region
(sequence = ASWS, Fig. 1), with respect to that of
SIV gp41. In the present model, the four residue
insert assumes a small turn conformation, in the ab-
sence of NOE or dihedral restraints. Interestingly,
the C1 domain of gp120 contains a ¢ve residue in-
sertion with respect to SIV gp120, which is consistent
with the notion that the gp41 loop region binds to
the gp120 C1 domain [26]. In summary, the model of
the HIV gp41 ectodomain lends insight into the
structure of the loop region, which has been impli-
cated to be involved with intermolecular interactions,
but is missing from all X-ray structures of HIV gp41.
In Fig. 2c, the space-¢lling model of the HIV gp41
ectodomain is shown. In this presentation, the pos-
itively and negatively charged moieties are colored
blue and red, respectively; the hydrophobic moieties
Fig. 2. Model for the HIV gp41 ectodomain. (a) An ensemble of ten low energy structures. The N-terminal helices are colored cyan,
the loop region is colored green, and the C-terminal helices are colored red. (b) Ribbon diagram of the minimized mean structure
with each presented as a unique color. The locations of the disul¢de bond and amino acid insertion are denoted. (c) Space ¢lling rep-
resentation of the minimized mean structure with the acidic moieties colored red, basic moieties colored blue, and hydrophobic moi-
eties colored green.
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are colored green. There are two striking properties
of the HIV gp41 loop region, which are relevant to
the proposed interactions with gp120 and C1q. First,
the loop region exhibits an absence of charged resi-
dues and an abundance of exposed hydrophobic side
chains, which are characteristics of protein-protein
interaction sites [27,28]. The presence of hydrophobic
residues on the surface of the gp41 loop is also ob-
served in the solution structure of the SIV gp41 ec-
todomain, which was determined by NMR spectros-
copy [16]. Moreover, the hydrophobicity of the loop
region is consistent with the amino acid sequence of
the loop region, for which there are only four
charged residues within the 30 residue loop sequence
(Fig. 1). Second, the space ¢lling representation of
the HIV gp41 ectodomain clearly shows that the
loop region forms a cleft, which could be comple-
mentary to the binding of globular domains of
gp120 and C1q. The structure of the HIV gp41
loop region allows re-examination of previous studies
implicating a prominent role in the gp41 interaction
with gp120 and C1q of the complement system. With
respect to the gp41-gp120 interaction, mutations at
positions W57 and V69 of the HIV gp41 ectodomain,
which are found in the loop region (Fig. 1), have
been shown to disrupt gp120 binding [19]. More re-
cently, in an e¡ort to stabilize the gp41-gp120 inter-
action, a number of gp41 and gp120 residues were
substituted with cysteines. The formation of non-na-
tive disul¢de bonds between gp41 and gp120 can
then be inferred as evidence for a direct interaction
between the respective regions of gp41 and gp120
[20]. As shown by Fig. 3a, the most reactive residues
of gp41 are located in the loop region. Importantly,
the disul¢de-linked complex exhibits antigenic prop-
erties that are similar to the gp41-gp120 complex
found in virions [20]. In the case of the gp41-C1q
interaction, synthetic peptides corresponding to the
gp41 loop region have been shown to bind to C1q
[21,22]. The gp41 residues implicated in binding to
C1q are highlighted in Fig. 3b. Recently, HIV-1 has
been shown to infect B cells via the complement sys-
tem [23]. In light of the binding of gp41 to C1q of the
complement system, the loop region of gp41 may be
inferred to play an important role in the infection of
B cells. Finally, we note that HIV-1 induced comple-
ment activation is stronger upon shedding of gp120
[29]. This observation is consistent with the notion
that gp120 and C1q have overlapping binding sites
within the gp41 loop region.
Taken together, the present model is consistent
with mounting evidence that the HIV gp41 loop re-
Fig. 3. (a) Ribbon diagram of the HIV gp41 loop region. gp41 residues that exhibit disul¢de bonds to gp120 C1 and C5 domains,
when substituted by non-native cysteines [20] are presented as yellow spheres on one subunit. The size of the sphere represents the rel-
ative reactivity of the gp41 mutant. Numbering corresponds to that of the HIV gp41 ectodomain (Fig. 1). (b) Space ¢lling representa-
tion of the HIV gp41 loop region. gp41 residues implicated in binding to C1q are colored green.
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gion is directly involved in binding to gp120 and C1q
of the complement system. It is important to note
that the present model assumes that the structure
of the gp41 loop region represents the gp41 confor-
mation that binds to gp120 and C1q. It is presently
being debated whether the helical regions of the gp41
ectodomain undergo large conformational changes
during HIV infection (cf. [2,10,11,16]). However,
there is no direct evidence that the loop region
undergoes conformational changes during HIV infec-
tion. In any event, the critical role of gp41 in HIV
infection suggests that further studies of gp41 inter-
molecular interactions are clearly warranted.
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